PDS Biotech Announces New U.S. Patent Covering Technology Underlying PDS0101

PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...
Yahoo Finance

PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering

PRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the ...
Seeking Alpha

PDS Precision Drilling Corporation

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

PDS Biotech Announces FDA Alignment on use of Progression Free Survival (PFS) as Primary Endpoint

PDS Biotech Submits Amended Protocol for Phase 3 VERSATILE-003 TrialConstructive Type C Meeting Provides Potential Pathway to Accelerated ...